Abstract P287: Therapeutic Hypothermia Cardioprotection During Cardiac Arrest Alters Reperfusion-Associated Mtorc1 and AMPK Signaling

Willard W Sharp,David Beiser,Zuo-Hui Shao,Mei Han,Chang-Qing Li,Jing Li,Huashan Wang,Kimm Hamann,Terry Vanden Hoek

DOI: https://doi.org/10.1161/res.109.suppl_1.ap287

IF: 23.213

2011-01-01

Circulation Research

Abstract:Introduction: Therapeutic hypothermia (TH) is highly cardioprotective in cellular and animal models of ischemia/reperfusion (I/R) and cardiac arrest and is dependent upon Akt. The mammalian target of rapamycin complex 1 (mTORC1) is a downstream target of Akt and an important regulator of cellular energy utilization and survival but its relationship to TH is not clear. We hypothesized that TH attenuates mTORC1 activation while simultaneously activating the cell survival kinases AMP activated protein kinase (AMPK) and Stat3. We further hypothesized that inhibitors of mTORC1 or activators of AMPK would replicate and/or enhance TH cardioprotection. Methods: Cardiomyocytes isolated from 1-2-day old C57BL6/J mice, were exposed to simulated I (90 min)/R (3 h). For TH, cells were cooled from 37C to 32C during ischemia and the first hour of reperfusion. Heart samples were also obtained from C57BL/6 mice that underwent an 8-min cardiac arrest. Following 6 min, the mice were randomized to normothermia (NT, 37C) or TH (30C) extended during CPR and for 1 h after resuscitation. Protein lysates were collected at serial time points for Western blot analyses. Results: Cardiomyocyte death during ischemia was minimal, but accelerated during reperfusion (4% vs. 46%,p Conclusion: TH cardioprotection is associated with altered signaling events suggesting mTORC1 inhibition and activation of the cell survival kinases AMPK and Stat3. Pharmacologic strategies that mimic these TH effects are available and could be useful as TH adjuncts or mimetics that improve survival after cardiac arrest.